Publication | Closed Access
New-onset inflammatory bowel diseases among IL-17 inhibitor-treated patients: results from the case–control MISSIL study
12
Citations
15
References
2021
Year
The incidence of new IBD was low and decreased from 2016 to 2019. The outcome was favourable in 24 out of 31 patients, but two patients died.
| Year | Citations | |
|---|---|---|
Page 1
Page 1